Ding Ma: Clinical Trials

3 unknown, 2 active not recruiting, 1 enrolling by invitation. 2 Phase 3, 1 Not applicable.

By phase and status

Phase	Trials	Status
Phase 3	2	Active not recruiting 1, Unknown 1
Not applicable	1	Active not recruiting 1

Follow Ding Ma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix Cervix Cancer, Cadonilimab		Enrolling by invitation	Ding Ma	20	2025-02-01	2025-02-06
Clinical Evaluation of HPV Integration Triage for Detection of Cervical Precancer in HPV-positive Women HPV integration test - HPV Infection, Cervical Cancer		Unknown	Ding Ma	2200	2022-01-01	2022-10-06
Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia MTX 1, MTX 2, Act-d - Gestational Trophoblastic Disease, Gestational Trophoblastic Neoplasia	Phase 3	Unknown	Ding Ma	300	2012-12-01	2019-12-24
The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma Paclitaxel, Paraplatin (Carboplatin Injection), Pelvic Radiation - Endometrial Neoplasms	Phase 3	Active not recruiting	Ding Ma	300	2012-11-01	2024-04-02
The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma TH, TH/BSO, BPLND - Endometrial Neoplasms	Not applicable	Active not recruiting	Ding Ma	240	2012-11-01	2024-04-02
Model Development and Prospective Validation to Predict the Response to Neoadjuvant Chemotherapy in Cervical Cancer Cervical Cancer		Unknown	Ding Ma	1400		2016-05-17

Conditions studied

Uterine Cervical Neoplasms (3)  ·  Endometrial Neoplasms (2)  ·  Gestational Trophoblastic Disease (1)  ·  Papillomavirus Infections (1)

Interventions

Carboplatin (1)  ·  Dactinomycin (1)  ·  Paclitaxel (1)

Countries

China (6)

Top investigators

Beihua Kong, MD, PhD (2)  ·  Xing Xie, MD, PhD (1)